PMC:7405836 / 105689-105856 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T947","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A947","pred":"mondo_id","subj":"T947","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Before choosing the ideal therapeutic agent for the management of COVID-19, randomized clinical control studies should be performed with a sufficient study population."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T36","span":{"begin":137,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Before choosing the ideal therapeutic agent for the management of COVID-19, randomized clinical control studies should be performed with a sufficient study population."}

{"project":"LitCovid-sentences","denotations":[{"id":"T724","span":{"begin":0,"end":167},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Before choosing the ideal therapeutic agent for the management of COVID-19, randomized clinical control studies should be performed with a sufficient study population."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2823","span":{"begin":66,"end":74},"obj":"Disease"}],"attributes":[{"id":"A2823","pred":"tao:has_database_id","subj":"2823","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Before choosing the ideal therapeutic agent for the management of COVID-19, randomized clinical control studies should be performed with a sufficient study population."}